Biotechnology

Genetic Engineering Drug Development Genetics Nanotechnology Pharmaceuticals Vaccine Development Gene Therapy Research and Development Gene Editing Synthetic Biology

Bath Researchers Advance New Hantavirus Vaccine Using mRNA and Silica Stabilization

The project pairs mRNA with a silica coating to keep doses stable without refrigeration.

Stories older than 24h

Colossal Says Gene-Edited ‘Dire Wolves’ Have Reached Breeding Age

Roche to Acquire PathAI for $750 Million Upfront Plus Up to $300 Million in Milestones

Study Details VeloCD Blood Method to Predict Illness Trajectory

CRISPR Enzyme Cas12a2 Selectively Destroys Cells Based on RNA in Lab Tests

UCB to Buy Candid Therapeutics for Up to $2.2 Billion

Mayo Clinic AI Flags Pancreatic Cancer on CT Years Before Diagnosis

LEO Pharma to Acquire Replay in $50 Million Gene-Therapy Deal

Former Harvard Scientist Charles Lieber Now Leads China’s State-Backed Brain-Interface Program

AI-Designed E. coli Ribosomes Operate Without Isoleucine

Pfizer Settles With Three Generics to Keep Vyndamax Exclusive Until 2031

Lilly and Profluent Strike AI Gene-Editing Pact Worth Up to $2.25 Billion

Gilead Closes $7.8 Billion Arcellx Deal to Take Full Control of Anito‑cel

Sagimet Prices $175 Million Stock Offering as It Plans U.S. Phase 3 Acne Trial

Lilly to Acquire Ajax Therapeutics in Up to $2.3 Billion Blood Cancer Deal

Injection Eases Breathing in Flat-Faced Dogs in Small Australian Trial

On-Demand Nanobody Probes Sharpen Live Imaging by Lighting Up Only at Targets

Trump Order to Speed Psychedelic Therapies Sends Compass Pathways to 52-Week High

Nanopillared Plastic Film Rips Virus Particles Apart on Contact

Eli Lilly to Buy Kelonia for Up to $7 Billion to Gain In‑Vivo CAR‑T Platform